Literature DB >> 24677762

FKBP14-related Ehlers-Danlos syndrome: expansion of the phenotype to include vascular complications.

Mitzi L Murray1, Margaret Yang, Christine Fauth, Peter H Byers.   

Abstract

Biallelic mutations in FKBP14 cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss. To date, four children and one adult with this condition have been reported. We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, short stature, mild hearing loss, decreased muscle mass, and a dissection of the celiac artery at age 41. He also had complete occlusion of the superior mesenteric artery with compensatory flow through an enlarged and tortuous inferior mesenteric artery. He was homozygous for a previously identified FKBP14 mutation, c.362dupC, p.(Glu122Argfs*7). He had no mutations in COL3A1, ACTA2, TGFBR1, TGFBR2, or SMAD3. The FKBP14 mutations in our patient occurred on the same haplotype as others with this same mutation. Although one family member in a previous report was thought to have early vascular complications, it could not be confirmed that she had biallelic mutations in FKBP14. This report expands the phenotype of FKBP14-related EDS to include risk for vascular complications and also raises the question of whether the shared haplotype represents a risk allele or founder mutation.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ehlers-Danlos syndrome; FKBP14; arterial dissection; kyphoscoliosis

Mesh:

Substances:

Year:  2014        PMID: 24677762     DOI: 10.1002/ajmg.a.36492

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  Downregulation of FKBP14 by RNA interference inhibits the proliferation, adhesion and invasion of gastric cancer cells.

Authors:  Ruizhong Wang; Hua Fang; Qin Fang
Journal:  Oncol Lett       Date:  2017-02-28       Impact factor: 2.967

Review 2.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

3.  Ziploc-ing the structure 2.0: Endoplasmic reticulum-resident peptidyl prolyl isomerases show different activities toward hydroxyproline.

Authors:  Yoshihiro Ishikawa; Kazunori Mizuno; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2017-04-06       Impact factor: 5.157

4.  A cohort of 17 patients with kyphoscoliotic Ehlers-Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history.

Authors:  Cecilia Giunta; Matthias Baumann; Christine Fauth; Uschi Lindert; Ebtesam M Abdalla; Angela F Brady; James Collins; Jahannaz Dastgir; Sandra Donkervoort; Neeti Ghali; Diana S Johnson; Ariana Kariminejad; Johannes Koch; Marius Kraenzlin; Nayana Lahiri; Bernarda Lozic; Adnan Y Manzur; Jenny E V Morton; Jacek Pilch; Rebecca C Pollitt; Gudrun Schreiber; Nora L Shannon; Glenda Sobey; Anthony Vandersteen; Fleur S van Dijk; Martina Witsch-Baumgartner; Johannes Zschocke; F Michael Pope; Carsten G Bönnemann; Marianne Rohrbach
Journal:  Genet Med       Date:  2017-06-15       Impact factor: 8.822

5.  Ehlers-Danlos syndrome kyphoscoliotic type 2 caused by mutations in the FKBP14 gene: an analysis of five cases.

Authors:  Alla Nikolaevna Semyachkina; Ekaterina Alexandrovna Nikolaeva; Nailya Mansurovna Galeeva; Alexander Vladimirovich Polyakov; Maria Andreevna Kurnikova; Vera Аlexandrovna Belova; Irina Valerievna Shulyakova; Ilya Sergeevich Dantsev; Goar Vladimirovna Dzhivanshiryan
Journal:  F1000Res       Date:  2021-06-25

Review 6.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

7.  Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.

Authors:  Nicola Chiarelli; Giulia Carini; Nicoletta Zoppi; Marco Ritelli; Marina Colombi
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

Review 8.  Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.

Authors:  Sanne D'hondt; Tim Van Damme; Fransiska Malfait
Journal:  Genet Med       Date:  2017-10-05       Impact factor: 8.822

9.  RNAi-Mediated Downregulation of FKBP14 Suppresses the Growth of Human Ovarian Cancer Cells.

Authors:  Meng Lu; Yi Miao; Lan Qi; Mingzhu Bai; Jiarong Zhang; Youji Feng
Journal:  Oncol Res       Date:  2016       Impact factor: 5.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.